The requirement for cyclin E in c-Myc overexpressing breast cancers
收藏DataCite Commons2024-02-23 更新2024-08-18 收录
下载链接:
https://tandf.figshare.com/articles/dataset/The_requirement_for_cyclin_E_in_c-Myc_overexpressing_breast_cancers/13007873
下载链接
链接失效反馈官方服务:
资源简介:
Basal-like triple-negative breast cancers frequently express high levels of c-Myc. This oncoprotein signals to the core cell cycle machinery by impinging on cyclin E. High levels of E-type cyclins (E1 and E2) are often seen in human triple-negative breast tumors. In the current study, we examined the requirement for E-type cyclins in the c-Myc-driven mouse model of breast cancer (MMTV-c-Myc mice). To do so, we crossed cyclin E1- (E1<sup>-/-</sup>) and E2- (E2<sup>-/-</sup>) deficient mice with MMTV-c-Myc animals, and observed the resulting cyclin E1<sup>-/-</sup>/MMTV-c-Myc and cyclin E2<sup>-/-</sup>/MMTV-c-Myc females for breast cancer incidence. We found that mice lacking cyclins E1 or E2 developed breast cancers like their cyclin Ewild-type counterparts. In contrast, further reduction of the dosage of E-cyclins in cyclin E1<sup>-/-</sup>E2<sup>+/-</sup>/MMTV-c-Myc and cyclin E1<sup>+/-</sup>E2<sup>-/-</sup>/MMTV-c-Myc animals significantly decreased the incidence of mammary carcinomas, revealing arole for E-cyclins in tumor initiation. We also observed that depletion of E-cyclins in human triple-negative breast cancer cell lines halted cell cycle progression, indicating that E-cyclins are essential for tumor cell proliferation. In contrast, we found that the catalytic partner of E-cyclins, the cyclin-dependent kinase 2 (CDK2), is dispensable for the proliferation of these cells. These results indicate that E-cyclins, but not CDK2, play essential and rate-limiting roles in driving the proliferation of c-Myc overexpressing breast cancer cells.
基底样三阴性乳腺癌(basal-like triple-negative breast cancer)通常高表达c-Myc蛋白。该癌蛋白通过靶向作用于E型周期蛋白,向细胞周期核心调控系统传递信号。人类三阴性乳腺肿瘤中常可检测到高表达的E型周期蛋白(E1与E2)。
在本研究中,我们针对c-Myc驱动的乳腺癌小鼠模型(MMTV-c-Myc小鼠),探究了E型周期蛋白的必要性。为此,我们将E1基因敲除(E1<sup>-/-</sup>)与E2基因敲除(E2<sup>-/-</sup>)小鼠分别与MMTV-c-Myc小鼠进行杂交,对获得的雌性双基因型小鼠cyclin E1<sup>-/-</sup>/MMTV-c-Myc及cyclin E2<sup>-/-</sup>/MMTV-c-Myc的乳腺癌发病率进行观测。
我们发现,缺失E1或E2型周期蛋白的小鼠,其乳腺癌发病率与野生型E型周期蛋白对照小鼠无显著差异。与之相反,在cyclin E1<sup>-/-</sup>E2<sup>+/-</sup>/MMTV-c-Myc及cyclin E1<sup>+/-</sup>E2<sup>-/-</sup>/MMTV-c-Myc小鼠中进一步降低E型周期蛋白的基因拷贝数,可显著降低乳腺腺癌的发病率,揭示了E型周期蛋白在肿瘤起始过程中的作用。
我们同时观测到,在人类三阴性乳腺癌细胞系中敲除E型周期蛋白可阻断细胞周期进程,表明E型周期蛋白对肿瘤细胞增殖至关重要。
与之相反,我们发现E型周期蛋白的催化伴侣——细胞周期蛋白依赖性激酶2(cyclin-dependent kinase 2, CDK2)——对这类细胞的增殖并非必需。
上述结果表明,E型周期蛋白而非CDK2,在驱动c-Myc过表达乳腺癌细胞增殖的过程中发挥了必需且限速的关键作用。
提供机构:
Taylor & Francis
创建时间:
2020-09-25



